Pseudomonas aeruginosa from cystic fibrosis patients: study using whole cell RAPD and antibiotic susceptibility
- PMID: 9769892
Pseudomonas aeruginosa from cystic fibrosis patients: study using whole cell RAPD and antibiotic susceptibility
Abstract
Pseudomonas aeruginosa is the most important bacterial pathogen in lung disease of cystic fibrosis patients. Different morphotypes of the bacterium are frequently recovered in sputum samples of these patients. We developed a whole cell Randomly Amplified Polymorphic DNA (RAPD) technique in order to establish the relatedness between morphotype, genotype and antibiotic susceptibility. Six cystic fibrosis patients already colonized by P. aeruginosa were investigated by collecting three successive sputum samples (before and after antibiotic treatment, and one month later) and selecting 10 isolates per morphotype. 250 isolates of P. aeruginosa were recovered from 16 of 18 sputum samples. Five patients carried a single RAPD type strain four of which showed at least two morphotypes; one patient carried two RAPD types strains. No patients carried the same strain. These results confirmed other studies previously published in showing stability of the chronic colonization with a single strain. Antibiotype differences were not associated with differences of RAPD profiles and no relation was found between antibiotype and morphotype.
Similar articles
-
Characterization of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients by different typing methods.Pathol Biol (Paris). 2011 Oct;59(5):e109-14. doi: 10.1016/j.patbio.2009.06.002. Epub 2009 Nov 5. Pathol Biol (Paris). 2011. PMID: 19896303
-
Genotype and antibiotic susceptibility patterns of Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients.Jpn J Infect Dis. 2007 May;60(2-3):82-6. Jpn J Infect Dis. 2007. PMID: 17515637
-
Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.Respirology. 2008 Nov;13(6):886-92. doi: 10.1111/j.1440-1843.2008.01383.x. Respirology. 2008. PMID: 18811887
-
Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.APMIS Suppl. 2003;(116):1-47. APMIS Suppl. 2003. PMID: 14692154 Review.
-
Clinical utility of synergy testing for multidrug-resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis: 'the motion for'.Paediatr Respir Rev. 2007 Sep;8(3):249-55. doi: 10.1016/j.prrv.2007.04.006. Epub 2007 Jun 5. Paediatr Respir Rev. 2007. PMID: 17868923 Review.
Cited by
-
Mutation frequencies and antibiotic resistance.Antimicrob Agents Chemother. 2000 Jul;44(7):1771-7. doi: 10.1128/AAC.44.7.1771-1777.2000. Antimicrob Agents Chemother. 2000. PMID: 10858329 Free PMC article. Review. No abstract available.
-
Pseudomonas aeruginosa isolates from dental unit waterlines can be divided in two distinct groups, including one displaying phenotypes similar to isolates from cystic fibrosis patients.Front Microbiol. 2015 Jan 21;5:802. doi: 10.3389/fmicb.2014.00802. eCollection 2014. Front Microbiol. 2015. PMID: 25653647 Free PMC article.
-
Instantaneous within-patient diversity of Pseudomonas aeruginosa quorum-sensing populations from cystic fibrosis lung infections.Infect Immun. 2009 Dec;77(12):5631-9. doi: 10.1128/IAI.00755-09. Epub 2009 Oct 5. Infect Immun. 2009. PMID: 19805523 Free PMC article.
-
Coexistence and within-host evolution of diversified lineages of hypermutable Pseudomonas aeruginosa in long-term cystic fibrosis infections.PLoS Genet. 2014 Oct 16;10(10):e1004651. doi: 10.1371/journal.pgen.1004651. eCollection 2014 Oct. PLoS Genet. 2014. PMID: 25330091 Free PMC article.
-
Characterization of cell-to-cell signaling-deficient Pseudomonas aeruginosa strains colonizing intubated patients.J Clin Microbiol. 2004 Feb;42(2):554-62. doi: 10.1128/JCM.42.2.554-562.2004. J Clin Microbiol. 2004. PMID: 14766816 Free PMC article.